• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型抗体黑素-A与S100蛋白及HMB-45在恶性黑色素瘤及黑色素瘤变异型中的免疫组化染色比较

Comparison of immunohistochemical staining of the novel antibody melan-A with S100 protein and HMB-45 in malignant melanoma and melanoma variants.

作者信息

Blessing K, Sanders D S, Grant J J

机构信息

Department of Histopathology, Worthing Hospital, West Sussex, UK.

出版信息

Histopathology. 1998 Feb;32(2):139-46. doi: 10.1046/j.1365-2559.1998.00312.x.

DOI:10.1046/j.1365-2559.1998.00312.x
PMID:9543670
Abstract

AIMS

The staining pattern of the recently described antibody melan-A was compared with those of S100 protein and HMB-45 in a variety of melanocytic lesions to assess the specificity and sensitivity of these antibodies.

METHODS AND RESULTS

Immunohistochemical staining of paraffin sections of a range of melanocytic lesions was carried out following a high temperature antigen retrieval technique. The pattern and intensity of staining was semiquantitatively scored. S100 remains the most sensitive marker of melanocytic differentiation being diffusely positive in all benign and all primary and secondary malignant lesions including naevoid melanomas, and in most desmoplastic/spindle cell melanomas. Of the two more specific melanocytic markers melan-A stains the majority of benign and malignant lesions diffusely but with occasional patchy positivity only in some secondary melanoma deposits and with little staining of desmoplastic/spindle cell melanomas. HMB-45 is the least sensitive of the three showing little positivity of benign mature naevus cells, only variable patchy positivity of primary and secondary melanoma cells and limited positivity in naevoid, desmoplastic and metastatic melanomas.

CONCLUSIONS

Melan-A is a useful addition to antibody panels as it is apparently specific for melanocytic lesions and is more sensitive than HMB-45; however, it has less value than S100 in the detection of spindle cell and desmoplastic melanomas.

摘要

目的

将最近描述的黑色素A抗体的染色模式与S100蛋白和HMB - 45在多种黑素细胞性病变中的染色模式进行比较,以评估这些抗体的特异性和敏感性。

方法与结果

采用高温抗原修复技术对一系列黑素细胞性病变的石蜡切片进行免疫组织化学染色。对染色的模式和强度进行半定量评分。S100仍然是黑素细胞分化最敏感的标志物,在所有良性、所有原发性和继发性恶性病变(包括痣样黑色素瘤)以及大多数促纤维增生性/梭形细胞黑色素瘤中均呈弥漫性阳性。在两种更具特异性的黑素细胞标志物中,黑色素A对大多数良性和恶性病变呈弥漫性染色,但仅在一些继发性黑色素瘤沉积物中偶尔出现斑片状阳性,而促纤维增生性/梭形细胞黑色素瘤几乎无染色。HMB - 45是三者中最不敏感的,良性成熟痣细胞几乎无阳性,原发性和继发性黑色素瘤细胞仅呈可变的斑片状阳性,在痣样、促纤维增生性和转移性黑色素瘤中呈有限阳性。

结论

黑色素A是抗体组合中的一个有用补充,因为它显然对黑素细胞性病变具有特异性,且比HMB - 45更敏感;然而,在检测梭形细胞和促纤维增生性黑色素瘤方面,它的价值低于S100。

相似文献

1
Comparison of immunohistochemical staining of the novel antibody melan-A with S100 protein and HMB-45 in malignant melanoma and melanoma variants.新型抗体黑素-A与S100蛋白及HMB-45在恶性黑色素瘤及黑色素瘤变异型中的免疫组化染色比较
Histopathology. 1998 Feb;32(2):139-46. doi: 10.1046/j.1365-2559.1998.00312.x.
2
Immunohistochemical diagnosis of malignant melanoma of the conjunctiva and uvea: comparison of the novel antibody against melan-A with S100 protein and HMB-45.结膜和葡萄膜恶性黑色素瘤的免疫组织化学诊断:新型抗黑素A抗体与S100蛋白及HMB-45的比较
Melanoma Res. 2000 Aug;10(4):350-4. doi: 10.1097/00008390-200008000-00006.
3
Melan-A/Mart-1 expression in various melanocytic lesions and in non-melanocytic soft tissue tumours.Melan-A/Mart-1在各种黑素细胞性病变及非黑素细胞性软组织肿瘤中的表达。
Histopathology. 1999 Jun;34(6):517-25. doi: 10.1111/j.1365-2559.1999.00679.x.
4
Comparison of immunohistochemical labelling of melanocyte differentiation antibodies melan-A, tyrosinase and HMB 45 with NKIC3 and S100 protein in the evaluation of benign naevi and malignant melanoma.在评估良性痣和恶性黑色素瘤时,黑色素细胞分化抗体melan-A、酪氨酸酶和HMB 45与NKIC3及S100蛋白的免疫组化标记比较
Histochem J. 2000 Aug;32(8):475-81. doi: 10.1023/a:1004192232357.
5
The usefulness of tyrosinase in the immunohistochemical assessment of melanocytic lesions: a comparison of the novel T311 antibody (anti-tyrosinase) with S-100, HMB45, and A103 (anti-melan-A).酪氨酸酶在黑素细胞性病变免疫组化评估中的应用:新型T311抗体(抗酪氨酸酶)与S-100、HMB45及A103(抗黑素A)的比较
J Clin Pathol. 2001 Mar;54(3):196-200. doi: 10.1136/jcp.54.3.196.
6
Immunoprofile of MITF, tyrosinase, melan-A, and MAGE-1 in HMB45-negative melanomas.HMB45阴性黑色素瘤中MITF、酪氨酸酶、黑色素A和MAGE-1的免疫表型
Am J Surg Pathol. 2002 Jan;26(1):82-7. doi: 10.1097/00000478-200201000-00010.
7
A103: An anti-melan-a monoclonal antibody for the detection of malignant melanoma in paraffin-embedded tissues.A103:一种用于检测石蜡包埋组织中恶性黑色素瘤的抗黑色素-a单克隆抗体。
Am J Surg Pathol. 1998 May;22(5):595-602. doi: 10.1097/00000478-199805000-00011.
8
Expression of melan-A (MART1) in benign melanocytic nevi and primary cutaneous malignant melanoma.黑色素A(MART1)在良性黑素细胞痣和原发性皮肤恶性黑色素瘤中的表达。
Am J Surg Pathol. 1998 Aug;22(8):976-82. doi: 10.1097/00000478-199808000-00007.
9
Microphthalmia transcription factor: not a sensitive or specific marker for the diagnosis of desmoplastic melanoma and spindle cell (non-desmoplastic) melanoma.小眼症转录因子:并非促纤维增生性黑色素瘤和梭形细胞(非促纤维增生性)黑色素瘤诊断的敏感或特异性标志物。
Am J Dermatopathol. 2001 Jun;23(3):185-9. doi: 10.1097/00000372-200106000-00004.
10
Expression of Melan-A and Ki-67 in desmoplastic melanoma and desmoplastic nevi.黑色素A和Ki-67在促纤维增生性黑色素瘤和促纤维增生性痣中的表达。
Am J Dermatopathol. 2004 Dec;26(6):452-7. doi: 10.1097/00000372-200412000-00002.

引用本文的文献

1
A Rare Case Of Pigmented Mammary Paget Disease.一例罕见的色素沉着性乳腺佩吉特病
Clin Cosmet Investig Dermatol. 2025 May 9;18:1163-1166. doi: 10.2147/CCID.S515553. eCollection 2025.
2
Proteogenomic Profiling of Treatment-Naïve Metastatic Malignant Melanoma.未经治疗的转移性恶性黑色素瘤的蛋白质基因组分析
Cancers (Basel). 2025 Feb 27;17(5):832. doi: 10.3390/cancers17050832.
3
A Narrative Review of the Evolution of Diagnostic Techniques and Treatment Strategies for Acral Lentiginous Melanoma.肢端雀斑样黑素瘤的诊断技术和治疗策略的演变:叙述性回顾。
Int J Mol Sci. 2024 Sep 27;25(19):10414. doi: 10.3390/ijms251910414.
4
Is primary breast melanoma a true pathological entity? The argument against it.原发性乳腺黑色素瘤是一种真正的病理实体吗?反对它的观点。
Heliyon. 2024 Aug 30;10(18):e37224. doi: 10.1016/j.heliyon.2024.e37224. eCollection 2024 Sep 30.
5
Treated Primary Cutaneous Malignant Melanoma With Later Metastasis Found in Clinical Presentation of Left Axilla Lymphadenopathy: A Case Report.以左腋窝淋巴结病为临床表现的经治疗的原发性皮肤恶性黑色素瘤伴后期转移:一例报告
Cureus. 2024 Feb 22;16(2):e54694. doi: 10.7759/cureus.54694. eCollection 2024 Feb.
6
Melan-A expression in non-melanocytic carcinoma: A potential diagnostic pitfall.黑色素A在非黑素细胞癌中的表达:一个潜在的诊断陷阱。
Histol Histopathol. 2024 Aug;39(8):1037-1041. doi: 10.14670/HH-18-696. Epub 2023 Dec 22.
7
Amelanotic Melanoma: A Great Masquerader.无色素性黑色素瘤:一个强大的伪装者。
J Lab Physicians. 2022 Oct 20;15(2):300-305. doi: 10.1055/s-0042-1757236. eCollection 2023 Jun.
8
Mammary Paget Disease With Melanocytic Proliferation Mimicking Malignant Melanoma : A Case Report.伴有黑素细胞增生酷似恶性黑色素瘤的乳腺佩吉特病:一例报告
Front Med (Lausanne). 2022 Mar 21;9:839954. doi: 10.3389/fmed.2022.839954. eCollection 2022.
9
Acremonidin E produced by sp. SNF123, a fungal endophyte of , has antimelanogenic activities.由植物的真菌内生菌SNF123菌株产生的顶孢菌素E具有抗黑色素生成活性。
J Ginseng Res. 2021 Jan;45(1):98-107. doi: 10.1016/j.jgr.2019.11.007. Epub 2019 Nov 21.
10
Clinical Relevance of Liquid Biopsy in Melanoma and Merkel Cell Carcinoma.液体活检在黑色素瘤和默克尔细胞癌中的临床相关性
Cancers (Basel). 2020 Apr 13;12(4):960. doi: 10.3390/cancers12040960.